Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Safety Profile of Nifurtimox for Treatment of Chagas Disease in the United States.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 15 Oct 2016

Forsyth Colin J, Hernandez Salvador, Olmedo Wilman, Abuhamidah Adieb, Traina Mahmoud I, Sanchez Daniel R, Soverow Jonathan, Meymandi Sheba K

Abstract excerpt

BACKGROUND: Nifurtimox is 1 of only 2 medications available for treating Chagas disease (CD) and currently the only drug available in the United States, but its safety and tolerance have not been extensively studied. This is the first study to evaluate tolerance of nifurtimox in US patients with CD. METHODS: This investigation assessed side effects in a sample of 53 patients with CD, all Latin American...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chagas Disease
Share to Drug-Related Side Effects and Adverse Reactions

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Kaplan-Meier Estimate

Share to Severity of Illness Index

Share to Symptom Assessment

Share to Trypanocidal Agents

Share to Trypanosoma cruzi

Share to United States

Source

Open in PubMed Open full text

Identifiers

PMID: 27432838
DOI: 10.1093/cid/ciw477
PMCID: PMC5036918

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

Safety Profile of Nifurtimox for Treatment of Chagas Disease in the United States.PMID 27432838Read ↗

Recommendations for the management of gastrointestinal comorbidities with or without trofinetide use in Rett syndromeSemantic proximity Read ↗

Neuro-Adverse Events Associated with GLP-1 Receptor Agonists: A Study Based on the FAERS Database and External Validation Using NHANES DatabaseSemantic proximity Read ↗

A Comprehensive Clinical Evaluation of Levocetirizine in the Treatment of Chronic Urticaria in ChildrenSemantic proximity Read ↗

Pharmacologic Therapies in Gastrointestinal Diseases.Semantic proximity Read ↗

Clinical response and side effects of metoclopramide: associations with clinical, demographic, and pharmacogenetic parameters.Semantic proximity Read ↗

Harmful “Herbalism” Maliciously Spreading from Mexico Determines Cases of Iatrogenic Cushing's SyndromeSemantic proximity Read ↗

Clinical Characteristics of Ciguatera Fish Poisoning in Martinique, French West Indies – A Case SeriesSemantic proximity Read ↗

Ondasetron in Premedication During Unsedated Upper Digestive Endoscopy: Evaluation of Tolerance and AcceptabilitySemantic proximity Read ↗

Treatment of functional gastrointestinal disorders associated with abdominal pain.Semantic proximity Read ↗

Lead Poisoning; a Neglected Potential Diagnosis in Abdominal PainSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.